361 related articles for article (PubMed ID: 25045997)
21. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
Comoglu T; Dilek Ozyilmaz E
Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
[TBL] [Abstract][Full Text] [Related]
22. Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets.
Gulsun T; Akdag Y; Izat N; Cetin M; Oner L; Sahin S
Pharm Dev Technol; 2020 Oct; 25(8):999-1009. PubMed ID: 32431206
[TBL] [Abstract][Full Text] [Related]
23. [Technical scheme of real-time evaluation of traditional Chinese medicine orally disintegrating tablets].
Qin D; Chen XD; Feng L; Gu JF; Yuan JR; Jia XB
Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(24):4716-22. PubMed ID: 25898566
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets.
Shoukri RA; Ahmed IS; Shamma RN
Eur J Pharm Biopharm; 2009 Sep; 73(1):162-71. PubMed ID: 19406232
[TBL] [Abstract][Full Text] [Related]
25. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
Dehghani H; Taheri A; Homayouni A
Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
[TBL] [Abstract][Full Text] [Related]
26. Development and optimization of lyophilized orally disintegrating tablets using factorial design.
Ahmed IS; Shamma RN; Shoukri RA
Pharm Dev Technol; 2013; 18(4):935-43. PubMed ID: 22107175
[TBL] [Abstract][Full Text] [Related]
27. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
Hooper P; Lasher J; Alexander KS; Baki G
J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
[TBL] [Abstract][Full Text] [Related]
28. Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets.
Sotoyama M; Uchida S; Kamiya C; Tanaka S; Kashiwagura Y; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
Chem Pharm Bull (Tokyo); 2019; 67(6):540-545. PubMed ID: 31155559
[TBL] [Abstract][Full Text] [Related]
29. Dissolution testing of orally disintegrating tablets.
Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
[TBL] [Abstract][Full Text] [Related]
30. An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.
Hobbs D; Karagianis J; Treuer T; Raskin J
Drugs R D; 2013 Dec; 13(4):281-8. PubMed ID: 24170256
[TBL] [Abstract][Full Text] [Related]
31. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
Mostafa HF; Ibrahim MA; Sakr A
Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
[TBL] [Abstract][Full Text] [Related]
32. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
Petrovick GF; Kleinebudde P; Breitkreutz J
Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
[TBL] [Abstract][Full Text] [Related]
33. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
[TBL] [Abstract][Full Text] [Related]
34. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
[TBL] [Abstract][Full Text] [Related]
36. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of novel multi-channel orally disintegrating tablets.
Yu J; Shan X; Chen S; Sun X; Song P; Zhao R; Hu L
Eur J Pharm Sci; 2020 Jan; 142():105108. PubMed ID: 31669391
[TBL] [Abstract][Full Text] [Related]
38. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
Rahman Z; Siddiqui A; Khan MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
[TBL] [Abstract][Full Text] [Related]
39. Geriatric-Oriented High Dose Nutraceutical ODTs: Formulation and Physicomechanical Characterization.
Agiba AM; Abdel-Hamid S; Nasr M; Geneidi AS
Curr Drug Deliv; 2018 Feb; 15(2):267-277. PubMed ID: 28322163
[TBL] [Abstract][Full Text] [Related]
40. The technologies used for developing orally disintegrating tablets: a review.
Badgujar BP; Mundada AS
Acta Pharm; 2011 Jun; 61(2):117-39. PubMed ID: 21684842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]